|
GB8504099D0
(en)
|
1985-02-18 |
1985-03-20 |
Wellcome Found |
Physiologically active substances
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
GB8610551D0
(en)
|
1986-04-30 |
1986-06-04 |
Hoffmann La Roche |
Polypeptide & protein derivatives
|
|
JPH0665280B2
(ja)
|
1987-03-04 |
1994-08-24 |
味の素株式会社 |
タンパクゲル化剤及びそれを用いるタンパクのゲル化方法
|
|
WO1994003198A1
(en)
|
1992-07-31 |
1994-02-17 |
Genentech, Inc. |
Human growth hormone aqueous formulation
|
|
DE68929273T2
(de)
|
1988-08-24 |
2001-07-05 |
American Cyanamid Co., Wayne |
Stabilisierung von Somatotropinen durch Modifikation von Cystein-Resten durch orts-spezifische Mutagenese oder chemische Derivatisierung
|
|
US6780613B1
(en)
|
1988-10-28 |
2004-08-24 |
Genentech, Inc. |
Growth hormone variants
|
|
US5534617A
(en)
|
1988-10-28 |
1996-07-09 |
Genentech, Inc. |
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
|
|
CA2345497A1
(en)
|
1988-10-28 |
1990-04-28 |
Genentech, Inc. |
Growth hormone variants and method for forming growth hormone variants
|
|
WO1990011296A1
(en)
|
1989-03-20 |
1990-10-04 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5101018A
(en)
|
1989-06-12 |
1992-03-31 |
International Minerals & Chemical Corp. |
Method for recovering recombinant proteins
|
|
DE3930696A1
(de)
|
1989-09-14 |
1991-03-28 |
Hoechst Ag |
Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
CA2073856C
(en)
|
1990-01-24 |
2002-12-03 |
Douglas I. Buckley |
Glp-1 analogs useful for diabetes treatment
|
|
US5951972A
(en)
|
1990-05-04 |
1999-09-14 |
American Cyanamid Company |
Stabilization of somatotropins and other proteins by modification of cysteine residues
|
|
JP2849773B2
(ja)
|
1990-08-27 |
1999-01-27 |
天野製薬株式会社 |
ストレプトミセス属由来のトランスグルタミナーゼの製造法
|
|
DK220890D0
(da)
|
1990-09-14 |
1990-09-14 |
Ole Buchardt |
Fremgangsmaade til fremstilling af c-terminalt amiderede peptider
|
|
DK0564531T3
(da)
|
1990-12-03 |
1998-09-28 |
Genentech Inc |
Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber
|
|
JP3267293B2
(ja)
|
1990-12-03 |
2002-03-18 |
ジェネンテク,インコーポレイテッド |
改変された結合性を有する変異タンパク質の豊富化法
|
|
IT1251895B
(it)
|
1991-09-27 |
1995-05-26 |
Eniricerche Spa |
Mutanti dell'ormone della crescita umano e loro impiego
|
|
EP0555649B1
(en)
|
1992-01-14 |
2004-12-08 |
Ajinomoto Co., Inc. |
Gene encoding transglutaminase derived from fish
|
|
ZA936811B
(en)
|
1992-10-28 |
1995-03-15 |
Upjohn Co |
Somatotropin modifications
|
|
US5359030A
(en)
|
1993-05-10 |
1994-10-25 |
Protein Delivery, Inc. |
Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
JP3758187B2
(ja)
|
1994-01-28 |
2006-03-22 |
味の素株式会社 |
マガキ由来のトランスグルタミナーゼ
|
|
ES2267103T3
(es)
|
1994-08-26 |
2007-03-01 |
Novozymes A/S |
Transglutaminasas microbianas, su produccion y uso.
|
|
EP0785276A4
(en)
|
1994-09-29 |
2002-01-09 |
Ajinomoto Kk |
MODIFICATION OF A PEPTIDE AND A PROTEIN
|
|
DE4437604A1
(de)
|
1994-10-21 |
1996-04-25 |
Basf Ag |
Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
|
|
NZ298746A
(en)
|
1995-01-19 |
1998-07-28 |
Novo Nordisk As |
Transglutaminases from oomcyetes
|
|
JP3669390B2
(ja)
|
1995-02-09 |
2005-07-06 |
味の素株式会社 |
バチルス属細菌由来のトランスグルタミナーゼ
|
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
|
JP3628333B2
(ja)
|
1995-09-21 |
2005-03-09 |
ジェネンテック インコーポレーテッド |
ヒト成長ホルモン変異体
|
|
US20020077461A1
(en)
|
1996-04-24 |
2002-06-20 |
Soren Bjorn |
Pharmaceutical formulation
|
|
IL128332A0
(en)
|
1996-08-30 |
2000-01-31 |
Novo Nordisk As |
GLP-1 derivatives
|
|
WO1998008872A1
(en)
|
1996-08-30 |
1998-03-05 |
Novo Nordisk A/S |
Glp-2 derivatives
|
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
WO1998013381A1
(fr)
|
1996-09-26 |
1998-04-02 |
Ajinomoto Co., Inc. |
Proteines modifiees physiologiquement actives et compositions medicamenteuses les contenant
|
|
US5985627A
(en)
|
1997-02-28 |
1999-11-16 |
Carlsberg Laboratory |
Modified carboxypeptidase
|
|
JPH1156378A
(ja)
|
1997-06-11 |
1999-03-02 |
Nippon Chem Res Kk |
変異型ヒト成長ホルモンとその用途
|
|
CN100404551C
(zh)
|
1997-06-25 |
2008-07-23 |
雪兰诺实验室有限公司 |
二硫键交联的糖蛋白激素类似物及其制备和应用
|
|
US6608183B1
(en)
|
1997-07-14 |
2003-08-19 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins
|
|
JPH1192499A
(ja)
*
|
1997-09-22 |
1999-04-06 |
Sumitomo Pharmaceut Co Ltd |
ヒト成長ホルモン変異体
|
|
US6136536A
(en)
|
1997-10-29 |
2000-10-24 |
Genetics Institute, Inc. |
Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
|
|
EP1060192A2
(en)
|
1998-02-27 |
2000-12-20 |
Novo Nordisk A/S |
Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
|
|
DE69942307D1
(de)
|
1998-02-27 |
2010-06-10 |
Novo Nordisk As |
N-terminal veränderte glp-1 abkömmlinge
|
|
WO1999043708A1
(en)
|
1998-02-27 |
1999-09-02 |
Novo Nordisk A/S |
Glp-1 derivatives of glp-1 and exendin with protracted profile of action
|
|
EP1056774A1
(en)
|
1998-02-27 |
2000-12-06 |
Novo Nordisk A/S |
N-terminally truncated glp-1 derivatives
|
|
ATE265224T1
(de)
|
1998-02-27 |
2004-05-15 |
Novo Nordisk As |
Glp-1 derivate mit einem helix-gehalt über 25 , die partiell strukturierte mizellenartige aggregate bilden
|
|
US6656922B2
(en)
|
1998-05-28 |
2003-12-02 |
Mediplex Corporation, Korea |
Oral delivery of macromolecules
|
|
US6358705B1
(en)
|
1998-07-16 |
2002-03-19 |
Novo Nordisk A/S |
Method of making proteins in transformed yeast cells
|
|
PL202367B1
(pl)
|
1998-12-07 |
2009-06-30 |
Sod Conseils Rech Applic |
Związki stanowiące analogi GLP-1, kompozycje zawierające te związki oraz zastosowanie tych związków
|
|
DE60006100T2
(de)
|
1999-05-17 |
2004-07-01 |
Conjuchem, Inc., Montreal |
Lang wirkende insulinotrope peptide
|
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
WO2001004287A1
(en)
|
1999-07-07 |
2001-01-18 |
Maxygen Aps |
A method for preparing modified polypeptides
|
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
|
GB2355009A
(en)
|
1999-07-30 |
2001-04-11 |
Univ Glasgow |
Peptides conjugated to bile acids/salts
|
|
US20040001827A1
(en)
|
2002-06-28 |
2004-01-01 |
Dennis Mark S. |
Serum albumin binding peptides for tumor targeting
|
|
AU2353701A
(en)
|
2000-01-11 |
2001-07-24 |
Novo Nordisk A/S |
Transepithelial delivery of glp-1 derivatives
|
|
EP2319541A1
(en)
|
2000-02-11 |
2011-05-11 |
Bayer HealthCare LLC |
Factor VII or VIIA-like conjugates
|
|
EP1803730A1
(en)
|
2000-04-12 |
2007-07-04 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
NZ522847A
(en)
*
|
2000-05-16 |
2004-11-26 |
Bolder Biotechnology Inc |
Methods for refolding proteins containing free cysteine residues
|
|
US20020142964A1
(en)
|
2000-11-02 |
2002-10-03 |
Nissen Torben Lauesgaard |
Single-chain polypeptides
|
|
ATE406384T1
(de)
|
2000-12-07 |
2008-09-15 |
Lilly Co Eli |
Glp-1 fusion proteine
|
|
AU2002219021A1
(en)
*
|
2001-01-11 |
2002-07-24 |
Maxygen Aps |
Variant growth hormone molecules conjugated with macromolecular compounds
|
|
US20060183197A1
(en)
|
2001-01-11 |
2006-08-17 |
Andersen Kim V |
Variant growth hormone molecules conjugated with macromolecules compounds
|
|
FR2819810B1
(fr)
|
2001-01-23 |
2004-05-28 |
Pf Medicament |
Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin
|
|
US6858580B2
(en)
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
|
DE60234193D1
(de)
|
2001-06-14 |
2009-12-10 |
Scripps Research Inst |
Stabilisierte faktor viii mit gentechnisch konstruierten disulfidbindungen
|
|
JP5562510B2
(ja)
|
2001-06-28 |
2014-07-30 |
ノヴォ ノルディスク アー/エス |
修飾glp−1の安定な処方剤
|
|
EP1423136A4
(en)
|
2001-08-10 |
2007-07-25 |
Epix Pharm Inc |
POLYPEPTIDE CONJUGATES HAVING INCREASED CIRCULATION HALF-VIES
|
|
AR036711A1
(es)
|
2001-10-05 |
2004-09-29 |
Bayer Corp |
Peptidos que actuan como agonistas del receptor del glp-1 y como antagonistas del receptor del glucagon y sus metodos de uso farmacologico
|
|
CA2463639A1
(en)
|
2001-11-12 |
2003-05-22 |
University Of Wales College Of Medicine |
Growth hormone variations in humans and their uses
|
|
OA13063A
(en)
|
2001-11-20 |
2006-11-10 |
Pharmacia Corp |
Chemically-modified human growth hormone conjugates.
|
|
JP2003199569A
(ja)
|
2001-12-17 |
2003-07-15 |
Food Industry Research & Development Inst |
ストレプトベルティシリウム・ラダカヌムのトランスグルタミナーゼ遺伝子及び該遺伝子によってコードされるトランスグルタミナーゼ
|
|
FR2836382B1
(fr)
|
2002-02-28 |
2004-08-13 |
Biomerieux Sa |
Nouveaux agents de couplages, leurs conjugues, ainsi que l'utilisation de ces conjugues dans des methodes de diagnostic
|
|
WO2004065621A1
(en)
|
2002-03-01 |
2004-08-05 |
Dyax Corp. |
Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
|
|
WO2003087139A2
(en)
|
2002-04-10 |
2003-10-23 |
Eli Lilly And Company |
Treatment of gastroparesis
|
|
BR0309576A
(pt)
|
2002-04-30 |
2005-02-09 |
Maxygen Holdings Ltd |
Variante de polipeptìdeo do fator vii (fvii) ou fator viia (fviia), sequência de nucleotìdeo, vetor de expressão, célula hospedeira, composição farmacêutica, uso de uma variante, e, método para tratar um mamìfero que tenha uma doença ou um distúrbio em que a formação de coágulo é desejável
|
|
EP1539960B1
(en)
|
2002-09-09 |
2010-04-28 |
Hanall Pharmaceutical Co., Ltd. |
Protease-resistant modified interferon alpha polypeptides
|
|
ATE455555T1
(de)
|
2003-02-19 |
2010-02-15 |
Ipsen Pharma |
Glp-1-analoga
|
|
AU2004235872A1
(en)
|
2003-05-09 |
2004-11-18 |
Novo Nordisk A/S |
Peptides for use in treating obesity
|
|
WO2005014035A2
(en)
|
2003-08-08 |
2005-02-17 |
Novo Nordisk Health Care Ag |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
|
EP1667724A2
(en)
|
2003-09-19 |
2006-06-14 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
RU2401276C2
(ru)
|
2003-09-19 |
2010-10-10 |
Ново Нордиск А/С |
Производные глюкагон-подобного пептида-1 (glp-1)
|
|
AU2004273573B2
(en)
|
2003-09-19 |
2010-04-22 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
CN100444898C
(zh)
|
2003-09-19 |
2008-12-24 |
诺沃挪第克公司 |
治疗肽的清蛋白结合型衍生物
|
|
JP2007508250A
(ja)
|
2003-10-10 |
2007-04-05 |
ノボ ノルディスク アクティーゼルスカブ |
持続性放出製剤における長期作用性分子
|
|
MXPA06006746A
(es)
|
2003-12-18 |
2006-08-18 |
Novo Nordisk As |
Analogos de glp-1 novedosos ligados a agentes similares a albumina.
|
|
WO2005058954A1
(en)
|
2003-12-18 |
2005-06-30 |
Novo Nordisk A/S |
Novel glp-1 compounds
|
|
ES2642214T3
(es)
|
2004-01-21 |
2017-11-15 |
Novo Nordisk Health Care Ag |
Conjugación de péptidos mediante transglutaminasa
|
|
BRPI0507169A
(pt)
|
2004-02-02 |
2007-06-26 |
Ambrx Inc |
polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
|
|
AU2005237775B2
(en)
|
2004-04-07 |
2010-03-04 |
Ares Trading S.A. |
Liquid growth hormone formulation
|
|
US7906137B2
(en)
|
2004-05-21 |
2011-03-15 |
Mediplex Corporation, Korea |
Delivery agents for enhancing mucosal absorption of therapeutic agents
|
|
AU2005261740A1
(en)
|
2004-07-08 |
2006-01-19 |
Novo Nordisk A/S |
Polypeptide protracting tags comprising a tetrazole moiety
|
|
EP1778838A2
(en)
|
2004-08-02 |
2007-05-02 |
Novo Nordisk Health Care AG |
Conjugation of fvii
|
|
WO2006037810A2
(en)
|
2004-10-07 |
2006-04-13 |
Novo Nordisk A/S |
Protracted glp-1 compounds
|
|
US7998930B2
(en)
*
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
|
EP1833993A4
(en)
|
2004-12-22 |
2009-07-22 |
Ambrx Inc |
HUMAN GROWTH HORMONE FORMULATIONS COMPRISING AN AMINO ACID CODED NON-NATURALLY
|
|
AU2006224537A1
(en)
|
2005-03-18 |
2006-09-21 |
Novo Nordisk A/S |
Extended GLP-1 compounds
|
|
TWI362392B
(en)
|
2005-03-18 |
2012-04-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
EP1863537A2
(en)
|
2005-03-18 |
2007-12-12 |
Novo Nordisk A/S |
Dimeric peptide agonists of the glp-1 receptor
|
|
EP1893632B1
(en)
|
2005-06-17 |
2015-08-12 |
Novo Nordisk Health Care AG |
Selective reduction and derivatization of engineered factor vii proteins comprising at least one non-native cysteine
|
|
CN101263225A
(zh)
|
2005-08-18 |
2008-09-10 |
诺沃-诺迪斯克保健股份有限公司 |
改进转谷氨酰胺酶的底物特异性
|
|
RU2008105545A
(ru)
|
2005-08-30 |
2009-10-10 |
Ново Нордиск Хелс Кеа Аг (Ch) |
Жидкие препараты пэгилированного гормона роста
|
|
CN1939534B
(zh)
|
2005-09-27 |
2010-12-01 |
长春金赛药业股份有限公司 |
含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
|
|
JP2009523815A
(ja)
*
|
2006-01-19 |
2009-06-25 |
アンブルックス,インコーポレイテッド |
免疫原性が調節された非天然アミノ酸ポリペプチド
|
|
US20090082254A1
(en)
|
2006-02-14 |
2009-03-26 |
Novo Nordisk A/S |
Coupling of Polypeptides at the C-Terminus
|
|
JP5252458B2
(ja)
|
2006-07-07 |
2013-07-31 |
ノボ ノルディスク ヘルス ケア アーゲー |
新規タンパク質コンジュゲート及びその製造方法
|
|
CA2672267C
(en)
|
2006-07-27 |
2016-05-31 |
Emisphere Technologies, Inc. |
Arylsulfanyl compounds and compositions for delivering active agents
|
|
JP2010500886A
(ja)
|
2006-08-18 |
2010-01-14 |
ノボ ノルディスク ヘルス ケア アーゲー |
改善された特異性を有するトランスグルタミナーゼ変異体
|
|
US20080095837A1
(en)
|
2006-08-31 |
2008-04-24 |
Emisphere Technologies, Inc. |
Human growth hormone formulations
|
|
BRPI0716261A2
(pt)
|
2006-08-31 |
2013-08-06 |
Novartis Ag |
composiÇÕes farmacÊuticas compreendendo hch para distribuiÇço oral
|
|
JP5390404B2
(ja)
|
2007-02-16 |
2014-01-15 |
エミスフェアー・テクノロジーズ・インク |
活性薬剤を送達するための環状部分を有する化合物及び組成物
|
|
WO2008112836A2
(en)
|
2007-03-15 |
2008-09-18 |
Novartis Ag |
Pharmaceutical composition comprising human growth hormon
|
|
WO2009030771A1
(en)
|
2007-09-05 |
2009-03-12 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
KR20110039348A
(ko)
|
2008-08-06 |
2011-04-15 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
연장된 생체내 효능을 가지는 콘쥬게이트된 단백질
|
|
US20110263501A1
(en)
|
2008-09-09 |
2011-10-27 |
Nono Nordisk Health Care AG |
Growth Hormone Conjugate with Increased Stability
|
|
ES2561208T3
(es)
|
2008-09-12 |
2016-02-25 |
Novo Nordisk A/S |
Método de acilación de un péptido o una proteína
|
|
JP5816097B2
(ja)
|
2009-01-22 |
2015-11-18 |
ノヴォ・ノルディスク・ヘルス・ケア・アーゲー |
安定な成長ホルモン化合物
|
|
CN102333788A
(zh)
|
2009-02-19 |
2012-01-25 |
诺沃—诺迪斯克有限公司 |
因子viii的修饰
|
|
CN105963710A
(zh)
|
2009-08-06 |
2016-09-28 |
诺沃—诺迪斯克保健股份有限公司 |
具有延长的体内功效的生长激素
|
|
RU2605627C2
(ru)
|
2010-01-22 |
2016-12-27 |
Ново Нордиск Хелс Кеа Аг |
Гормоны роста с пролонгированной эффективностью in vivo
|
|
BR112012018162A2
(pt)
|
2010-01-22 |
2017-10-03 |
Novo Nordisk Healthcare Ag |
Compostos de hormônio do crescimento estáveis
|
|
WO2011101261A2
(en)
|
2010-02-16 |
2011-08-25 |
Novo Nordisk A/S |
Purification method
|